Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2008;39:2560-2570
Published online before print July 17, 2008, doi: 10.1161/STROKEAHA.107.513150
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
39/9/2560    most recent
STROKEAHA.107.513150v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Terao, S.
Right arrow Articles by Granger, D. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Terao, S.
Right arrow Articles by Granger, D. N.
Related Collections
Right arrow Animal models of human disease
Right arrow Acute Cerebral Infarction

(Stroke. 2008;39:2560.)
© 2008 American Heart Association, Inc.


Original Contributions

Blood Cell-Derived RANTES Mediates Cerebral Microvascular Dysfunction, Inflammation, and Tissue Injury After Focal Ischemia–Reperfusion

Satoshi Terao, MD; Gokhan Yilmaz, MD; Karen Y. Stokes, PhD; Janice Russell, BS; Mami Ishikawa, MD, PhD; Takeshi Kawase, MD, PhD D. Neil Granger, PhD

From the Department of Molecular and Cellular Physiology (S.T., G.Y., K.Y.S., J.R., D.N.G.), Louisiana State University Health Sciences Center, Shreveport, La; the Department of Neurosurgery (M.I.), Jichi Medical University, Japan; and the Department of Neurosurgery (T.K.), Keio University Hospital, Japan.

Correspondence to D. Neil Granger, PhD, Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center, 1501 Kings Highway, Shreveport, LA 71130. E-mail dgrang{at}lsuhsc.edu

Background and Purpose— Although chemokines have been implicated in cardiovascular diseases, few studies have addressed the role of these inflammatory mediators in ischemic stroke. This study tested the hypothesis that RANTES (CCL5; regulated on activation, normal T-cell expressed and secreted) mediates the cerebral microvascular dysfunction, inflammation, and tissue injury induced by brain ischemia and reperfusion.

Methods— After 60-minute middle cerebral artery occlusion and reperfusion, the adhesion of leukocytes and platelets in cerebral venules, infarct volume, and blood–brain barrier permeability were measured in wild-type mice (WT), RANTES-deficient mice (RANTES–/–), WT mice transplanted with RANTES–/– bone marrow (RANTES>WT), and control bone marrow chimeras (WT>WT). The concentration of RANTES and several cytokines was also measured by enzyme-linked immunosorbent assay and a cytometric bead array.

Results— The enhanced leukocyte and platelet adhesion, increased blood–brain barrier permeability, and tissue infarction elicited in WT and WT>WT mice after middle cerebral artery occlusion and reperfusion were significantly blunted in RANTES–/– mice. Similar attenuation of the middle cerebral artery occlusion and reperfusion-induced responses were noted in RANTES>WT chimeras. Although RANTES deficiency did not alter the changes in tissue cytokine levels elicited by middle cerebral artery occlusion and reperfusion, plasma concentrations interleukin-6, interleukin-10, and interleukin-12 were all reduced.

Conclusions— These findings implicate blood cell-derived RANTES in the microvascular, inflammatory, and tissue injury responses of the brain to ischemia and reperfusion.


Key Words: cerebral infarct • chemokines • cytokines • platelets • RANTES




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Abu-Taha, C. Rius, C. Hermenegildo, I. Noguera, J.-M. Cerda-Nicolas, A. C. Issekutz, P. J. Jose, J. Cortijo, E. J. Morcillo, and M.-J. Sanz
Menopause and Ovariectomy Cause a Low Grade of Systemic Inflammation that May Be Prevented by Chronic Treatment with Low Doses of Estrogen or Losartan
J. Immunol., July 15, 2009; 183(2): 1393 - 1402.
[Abstract] [Full Text] [PDF]